TY  - JOUR
AU  - Santamaria, Manuel
AU  - Neth, Olaf
AU  - Douglass, Jo A
AU  - Krivan, Gergely
AU  - Kobbe, Robin
AU  - Bernatowska, Ewa
AU  - Grigoriadou, Sofia
AU  - Bethune, Claire
AU  - Chandra, Anita
AU  - Horneff, Gerd
AU  - Borte, Michael
AU  - Sonnenschein, Anja
AU  - Kralickova, Pavlina
AU  - Sanchez-Ramon, Silvia 
AU  - Langguth, Daman
AU  - Gonzalez-Granado, Luis Ignacio
AU  - Alsina, Laia
AU  - Querolt, Montse
AU  - Griffin, Rhonda
AU  - Hames, Carrie
AU  - Mondou, Elsa
AU  - Price, Jeffrey
AU  - Sanz, Ana
AU  - Lin, Jiang
PY  - 2022
DO  - 10.1007/s10875-021-01181-6
UR  - http://hdl.handle.net/10668/20596
T2  - Journal of clinical immunology
AB  - The purpose of this phase 3 study was to evaluate the efficacy, pharmacokinetics (PK), and safety of Immune Globulin Subcutaneous (Human), 20% Caprylate/Chromatography Purified (IGSC 20%) in patients with primary immunodeficiency (PI). Immunoglobulin...
LA  - en
PB  - Springer New York LLC
KW  - 20% immunoglobulin
KW  - GTI1503
KW  - Primary immunodeficiency
KW  - immunoglobulin replacement therapy
KW  - subcutaneous
KW  - Adolescent
KW  - Adult
KW  - Child
KW  - Humans
KW  - Immunoglobulin G
KW  - Immunoglobulins, Intravenous
KW  - Immunologic Deficiency Syndromes
KW  - Immunologic Factors
KW  - Infusions, Subcutaneous
TI  - A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.
TY  - research article
VL  - 42
ER  -